Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAAFinancial ServicesShell CompaniesUSD
Market open · Delayed 15 min · as of Oct 8, 12:01 PM ET
DMAA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $263.40M
- P/E (TTM)
- 60.28
- EPS (TTM)
- $0.18
- Dividend yield
- None
- 52-week range
- 10.26 – 10.89
- Day range
- 10.85 – 10.85
- Volume / Avg
- 1.27K / 21.64K
- Beta
- —
- Shares outstanding
- 24.28M
52-week range
DMAA stock today
Drugs Made In America Acquisition (DMAA) is trading at $10.85 on Oct 8, up 0.18% (+$0.02), versus the S&P 500's 0.60% decline. The stock is trading at or near its 52-week high of $10.89, 5.8% above the 52-week low of $10.26. Drugs Made In America Acquisition trades at 60.3x its trailing twelve-month earnings per share of $0.18.
Summary generated from market data by MetaCap's automated system. Methodology
About Drugs Made In America Acquisition
Company profileDrugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses.
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Roger Bendelac
- Headquarters
- New York, NY
- IPO year
- 2025
Drugs Made In America Acquisition peers
Financial Services sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NTWONewbury Street II Acquisition Corp Class A | 10.81 | -0.09% | $260.70M | vs DMAA |
| SCIISC II Acquisition Corp. Class A | 10.17 | 0.00% | $253.21M | vs DMAA |
| VLOSVelos Acquisition I Corp. Class A | 10.72 | -0.37% | $251.60M | vs DMAA |
| OHACOceanhawk Acquisition Corp. Class A | 9.98 | 0.00% | $250.14M | vs DMAA |
| MTAKMarket Technology Acquisition Corp Class A | 9.85 | 0.00% | $276.25M | vs DMAA |
| IPHXInflection Point Acquisition Corp. VIII Class A | 9.88 | -0.20% | $247.00M | vs DMAA |
| PNAQPinnacle Acquisition Corporation Class A | 9.84 | +0.10% | $246.00M | vs DMAA |
| SAMOSamos Energy Acquisition Corporation Class A | 9.80 | 0.00% | $281.75M | vs DMAA |
Indexes, lists and sector
Largest Financial Services stocks
Drugs Made In America Acquisition stock FAQ
What is Drugs Made In America Acquisition's stock price today?
DMAA last traded at $10.85 as of Oct 8, 12:01 PM EDT, up 0.18% on the day. Prices are delayed at least 15 minutes.
What is DMAA's P/E ratio?
DMAA trades at a trailing P/E ratio of 60.28.
Who is Drugs Made In America Acquisition's CEO?
Mr. Roger Bendelac is the chief executive officer of Drugs Made In America Acquisition Corp..
What is the DMAA 52-week high?
The 52-week high for DMAA is $10.89 and the 52-week low is $10.26. The stock is currently 0.4% below its high.